Therapeutic effect of terlipressin combined with albumin in 24 patients with hepatorenal syndrome
ObjectiveTo observe the therapeutic effect of terlipressin combined with albumin in management of patients with hepatorenal syndrome. MethodsA retrospective study enrolling 46 patients with hepatorenal syndrome from May 2011 to August 2013 was conducted, in which 22 patients were allocated to contro...
Main Author: | CHEN Si |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2014-08-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5934&ClassID=62613540 |
Similar Items
-
Low doses of terlipressin and albumin in the type I hepatorenal syndrome
by: Davide Pulvirenti, et al.
Published: (2013-05-01) -
Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico
by: Linda E. Muñoz, et al.
Published: (2009-07-01) -
Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
by: Mohamed M G Mohamed, et al.
Published: (2021-08-01) -
Hepatorenal Syndrome and Novel Advances in its Management
by: Fabrizio Fabrizi, et al.
Published: (2013-12-01) -
Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study
by: Gupta K, et al.
Published: (2018-09-01)